Paula P. Schnurr, PhD

  • 9Articles
  • 85.3KReads
  • 2013–2023Active
  • 41Collaborators
  • 862Citations

About

Paula P. Schnurr, PhD, is affiliated with the Executive Division of the National Center for PTSD in White River Junction, Vermont, and the Department of Psychiatry at the Geisel School of Medicine at Dartmouth in Hanover, New Hampshire. Her publications from 2013 to 2023 focus on Posttraumatic Stress Disorder, suicide risk assessment, and issues affecting veterans and military populations. Schnurr's work includes studies on medication effectiveness for PTSD, risk detection tools for suicide, and the validity of PTSD service connection status in veterans. She has frequently collaborated with co-authors such as Bradley V. Watts and Brian Shiner.

Publications

JCP
Antihypertensive Medications and PTSD
Original Research

Antihypertensive Medications and PTSD

August 2, 2023

Calcium channel blockers were linked to decreased incidence of PTSD; the association was not found for any other antihypertensive medication classes.
, , , et al
JCP
Tools to Detect Suicide Risk
Meta-Analysis

Tools to Detect Suicide Risk

November 16, 2022

More than 20 instruments have been developed to assist in detecting suicide risk in adults. This systematic review used likelihood ratio analysis to determine the diagnostic accuracy of instruments...
, , , et al
JCP
Original Research

Factors Associated With Response to PTSD Medications

October 5, 2021

This analysis of VA patients asked whether certain patients respond better than others to PTSD medications.
, , , et al
JCP
Original Research

Medications for DSM-5 PTSD

October 13, 2020

This retrospective study explored whether 5 medications for PTSD with efficacy in meta-analyses of randomized controlled trials—fluoxetine, paroxetine, sertraline, topiramate, and venlafaxine—are also effective in routine clinical practice.
, , , et al
JCP
Article

Comparing the Effectiveness of Medications for PTSD

September 18, 2018

When choosing among agents for treating PTSD, which one should you pick? Fluoxetine, paroxetine, sertraline, topiramate, and venlafaxine have all shown efficacy. This large retrospective VA study compared the...
, , , et al
JCP
Original Research

Anticonvulsants in PTSD

May 24, 2017

Anticonvulsants are often prescribed to veterans with PTSD, but how certain are we that these agents are effective for this indication? Read this analysis of medical records from the...
, , , et al
JCP
Original Research

Validity of Posttraumatic Stress Disorder Service Connection Status in Veterans Affairs Electronic Records of Iraq and Afghanistan Veterans

January 19, 2016

, , , et al
JCP
Article

Do Benzodiazepines Reduce the Effectiveness of Exposure Therapy for Posttraumatic Stress Disorder?

December 15, 2013

, , , et al
JCP
Meta-Analysis

Meta-Analysis of the Efficacy of Treatments for Posttraumatic Stress Disorder

June 15, 2013

, , , et al

Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.

Learn More About Psychedelics in Psychiatry

Explore the Collection
Neural network illustration symbolizing psychedelic research advancements

Subscribe to read
more articles

Subscribe